135 related articles for article (PubMed ID: 20492406)
1. Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway.
Miyazawa M; Yasuda M; Fujita M; Hirabayashi K; Hirasawa T; Kajiwara H; Muramatsu T; Miyazaki S; Harasawa M; Matsui N; Ogane N; Murakami M; Mikami M; Yanase T; Osamura RY
J Obstet Gynaecol Res; 2010 Apr; 36(2):448-53. PubMed ID: 20492406
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.
Naruse T; Kawasaki G; Yanamoto S; Mizuno A; Umeda M
Anticancer Res; 2011 Dec; 31(12):4429-37. PubMed ID: 22199311
[TBL] [Abstract][Full Text] [Related]
4. Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells.
Zhang Z; Yu D; Yin D; Wang Z
Anim Reprod Sci; 2011 May; 125(1-4):42-8. PubMed ID: 21477953
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.
Aleffi S; Navari N; Delogu W; Galastri S; Novo E; Rombouts K; Pinzani M; Parola M; Marra F
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G210-9. PubMed ID: 21252047
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
Wang Y; Zhao Q; Ma S; Yang F; Gong Y; Ke C
IUBMB Life; 2007 Nov; 59(11):717-21. PubMed ID: 17968710
[TBL] [Abstract][Full Text] [Related]
8. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of hypoxia-inducible factor-1alpha expression and vascular endothelial growth factor in SKOV-3 ovarian cancer model].
Jiang HY; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):767-70. PubMed ID: 15634505
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
11. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between hypoxia-inducible factor-1alpha expression and extracellular signal-regulated kinase in hypoxic-ischemic cortical neurons].
Zhang L; Qu Y; Zhang X; Yang C; Mao M; Mu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Aug; 23(8):954-8. PubMed ID: 19728613
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
14. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia-inducible factor-1alpha in nasal polyps and its correlation with vascular endothelial growth factor and inducible nitric oxide synthase].
Liu Y; Cui YH; Yu LL; Liu Z; Zhang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 May; 40(5):366-70. PubMed ID: 16229182
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Ameliorates Chronic Renal Failure in 5/6 Nephrectomized Rats by Regulation of the mTOR/HIF-1α/VEGF Signaling Pathway.
He Y; Lang X; Cheng D; Yang Z
Biol Pharm Bull; 2019 Jun; 42(6):886-891. PubMed ID: 30918132
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
19. [Expression of hypoxia-inducible factor-1α and vascular endothelial growth factor in the synovium of patients with osteoarthritis].
Duan X; Li Q; Lin LJ; Liu CL; Li ZH; Liu DJ; Zhang F
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):117-20. PubMed ID: 21269972
[TBL] [Abstract][Full Text] [Related]
20. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
